Contents

Current Medicinal Chemistry, Volume 13 - Number 15

Killing Time for Cancer Stem Cells (CSC): Discovery and Development of Selective CSC Inhibitors

, 13(15): 1719 - 1725

Maria Perez-Caro and Isidro Sanchez-Garcia


DOI: 10.2174/092986706777452533




Emerging Role of Intravascular Ultrasound in the Assessment of Experimental Anti-Atherosclerotic Therapies

, 13(15): 1727 - 1734

Stephen J. Nicholls and Ilke Sipahi


DOI: 10.2174/092986706777452498




Bringing Kinases Into Focus: Efficient Drug Design Through the Use of Chemogenomic Toolkits

, 13(15): 1735 - 1748

Veronique Birault, C. J. Harris, Joelle Le, Mike Lipkin, Ravi Nerella and Adrian Stevens


DOI: 10.2174/092986706777452452




Antiviral and Immunomodulatory Properties of New Pro-Glutathione (GSH) Molecules

, 13(15): 1749 - 1755

A. Fraternale, M. F. Paoletti, A. Casabianca, J. Oiry, P. Clayette, J.- U. Vogel, J. Jr. Cinatl, A. T. Palamara, R. Sgarbanti, E. Garaci, E. Millo, U. Benatti and M. Magnani


DOI: 10.2174/092986706777452542




Delivering Drugs to the Central Nervous System: A Medicinal Chemistry or a Pharmaceutical Technology Issue?

, 13(15): 1757 - 1775

Maurizio Ricci, Paolo Blasi, Stefano Giovagnoli and Carlo Rossi


DOI: 10.2174/092986706777452461




Novel Therapeutics for Diabetic Micro- and Macrovascular Complications

, 13(15): 1777 - 1788

A. Soro-Paavonen and J. M. Forbes


DOI: 10.2174/092986706777452515




Carbon Nanotubes: Materials for Medicinal Chemistry and Biotechnological Applications

, 13(15): 1789 - 1798

Georgia Pagona and Nikos Tagmatarchis


DOI: 10.2174/092986706777452524




Therapeutic Applications of Glycosaminoglycans

, 13(15): 1799 - 1810

Nicola Volpi


DOI: 10.2174/092986706777452470




Development of BACE1 Inhibitors for Alzheimers Disease

, 13(15): 1811 - 1829

Tao Guo and Doug W. Hobbs


DOI: 10.2174/092986706777452489




Clinical Proteomics: New Trends for Protein Microarrays

, 13(15): 1831 - 1837

K.- F. Becker, V. Metzger, S. Hipp and H. Hofler


DOI: 10.2174/092986706777452506




Small Molecule Glucokinase Activators as Glucose Lowering Agents: A New Paradigm for Diabetes Therapy

, 13(15): 1839 - 1843

Kevin R. Guertin and Joseph Grimsby


DOI: 10.2174/092986706777452551




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science